Related Experiment Videos
[A gene study on multidrug resistance of retinoblastoma]
1Department of Ophthalmology, Xiangya Second Hospital, Certral South University, Changsha 410011, China.
Objective:
To investigate the expression of multidrug resistance gene (MDR1) and multidrug associated protein (MRP) gene in the retinoblastoma (Rb) cell line HXO-RB(44), and study the mechanism of multidrug resistance (MDR) phenotype occurring in retinoblastoma.
Methods:
Reverse transcriptase polymerase chain reaction (RT-PCR) was employed to detect the transcription of MDR1 and MRP gene in the HXO-RB(44) cell line, and immunohistochemical technique was used to detect their protein products P-glycoprotein and multidrug resistance associated protein (P190).
Result:
Both MDR1 and MRP genes were expressed in HXO-RB(44) cell line, as well as P-glycoprotein and P190 were over-expressed (96% - 97%) in this cell line.
Conclusion:
Over-expression of MDR1 and MRP genes is significantly involved in the mechanism of MDR phenotype in retinoblastoma.
Insights
Multidrug resistance genes MDR1 and MRP are over-expressed in retinoblastoma cells, contributing to the multidrug resistance (MDR) phenotype. This finding highlights key mechanisms in retinoblastoma treatment resistance.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Context:
- Retinoblastoma (Rb) is a pediatric eye cancer.
- Multidrug resistance (MDR) is a significant challenge in Rb treatment.
- Understanding MDR mechanisms is crucial for improving therapeutic outcomes.
Purpose:
- To investigate the expression of multidrug resistance gene (MDR1) and multidrug associated protein (MRP) gene in the HXO-RB(44) Rb cell line.
- To elucidate the mechanism of the MDR phenotype in retinoblastoma.
Summary:
- Reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry were used to analyze MDR1 and MRP gene and protein expression (P-glycoprotein and P190) in the HXO-RB(44) cell line.
- Both MDR1 and MRP genes were found to be expressed.
- P-glycoprotein and P190 were over-expressed, with detection rates of 96%-97%.
Impact:
- The study demonstrates significant over-expression of MDR1 and MRP genes in retinoblastoma.
- This over-expression is a key factor in the MDR phenotype observed in retinoblastoma.
- Findings provide insights into therapeutic resistance, potentially guiding future treatment strategies for retinoblastoma.